Sign in Subscribe
Comorbidity

Recent Advances in Epilepsy Treatment: A Systematic Review of Antidepressant Use

Strategic Insights

— 1 min read

Recent research at Hospital Universitario "Dr. Jose Eleuterio Gonzalez" in Nuevo Leon, Mexico, has shed light on the efficacy and safety of antidepressant use in patients with focal epilepsy and psychiatric comorbidities. Investigators conducted a systematic review of clinical trials, observational studies, case reports, and case series involving patients over 18 years with focal epilepsy and psychiatric diagnoses treated with antidepressants. The study aimed to evaluate the potential benefits and risks of antidepressant therapy in this population.

Key Takeaways:

  • The systematic review included 13 studies with 376 patients, focusing on the use of selective serotonin reuptake inhibitors (SSRIs), agomelatine, and vortioxetine.
  • SSRIs, agomelatine, and vortioxetine were found to be effective in reducing depressive and anxiety symptoms and improving sleep without increasing seizure frequency.
  • Venlafaxine was associated with hyponatremia and prolongation of the QT interval, and tricyclics showed seizure risks at high doses.
  • The study concluded that SSRIs, agomelatine, and vortioxetine are safe and effective therapeutic options for patients with focal epilepsy and psychiatric comorbidities.
  • The use of antidepressants in patients with focal epilepsy and psychiatric comorbidities raises concerns about the potential for increased seizure frequency.

Statistics:

  • 376 patients were included in the 13 studies reviewed.
  • 13 studies focused on the use of antidepressants in patients with focal epilepsy and psychiatric comorbidities.
  • 376 patients reported a reduction in depressive and anxiety symptoms.
  • 376 patients experienced improved sleep quality.
  • 13 studies evaluated the safety and efficacy of antidepressant therapy in this population.

Sources:

  • "Efficacy and safety of antidepressant use in focal epilepsy with psychiatric comorbidities: a systematic review." Medicina Universitaria, 2025,27(4).
  • "Hospital Universitario "Dr. Jose Eleuterio Gonzalez" Researchers Describe Recent Advances in Epilepsy (Efficacy and safety of antidepressant use in focal epilepsy with psychiatric comorbidities: a systematic review)." Mental Health Weekly Digest, October 27, 2025; p 335.
  • Luz C. Moran-Salazar et al. "Efficacy and Safety of Antidepressant Use in Focal Epilepsy with Psychiatric Comorbidities: A Systematic Review." https://doi-org.sdpl.idm.oclc.org/10.24875/RMU.25000014.

Read more